Hansoh Pharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Hansoh Pharmaceutical Group
Access all reports
Hansoh Pharmaceutical Group is a Chinese pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative and generic drugs. The company’s product portfolio covers therapeutic areas such as oncology, central nervous system (CNS) disorders, anti-infectives, and diabetes. Hansoh Pharmaceutical places a strong emphasis on innovation, investing in R&D to expand its pipeline with both novel and high-quality generic drugs to address unmet medical needs. The company is headquartered in Lianyungang, China, and its shares are listed on the Hong Kong Stock Exchange.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
3692
Country
🇭🇰 Hong Kong